Le Lézard
Classified in: Health, Sports and recreation
Subjects: NEW PRODUCTS/SERVICES, HEALTH

Mikra PROTECT Immune Support Gummy Now Shipping


TORONTO, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, is pleased to report that its immune support product, PROTECT, is now available for sale at wearemikra.com. Introduced by its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. ("Mikra"), these immune support gummies continue Lifeist's commitment to offering natural, science-backed solutions to its valued customers. PROTECT is available for order directly at http://wearemikra.com/products/protect today.

"PROTECT is another example of our commitment to introducing science-backed natural solutions to everyday concerns. It combines the antioxidant power of Aronia berries with the immune support of zinc and key vitamins, delivering them all with the on-the-go convenience of a tasty gummy," said Meni Morim, CEO of Lifeist. "Following positive feedback from loyal early adopters of Mikra products, we are pleased to offer PROTECT for retail sale to everyone, now shipping from wearemikra.com."

PROTECT comes in a delicious gummy form factor that combines the antioxidant power of Aronia berries1 with the reliable immune support functions of zinc and vitamin C2, complemented by vitamins D and K.

A comprehensive U.S. clinical review underscored the benefits of Aronia berries as follows:

As documented in previous studies, Aronia berries show potent inhibitory activity toward various types of infections, which have been attributed to their potent antioxidant components.1

Furthermore, a Swiss clinical review concluded the following:

These trials document that adequate intakes of vitamin C and zinc ameliorate symptoms and shorten the duration of respiratory tract infections including the common cold.2

Mikra PROTECT gummies provide maximum support for your immune system, and are as notable for what they don't contain as for what they do: the precision blend features natural ingredients such as cane sugar, purified water, apple pectin, and aronia fruit powder. PROTECT gummies contain no artificial colors or flavors, no nuts, no corn, no GMOs, are gluten-free, lab-verified, and are 100% proudly made in the USA.

Mikra is pushing biosciences beyond the expected with the belief that it is possible to add more active, vigorous, enjoyable, and valuable years to your life through protecting and maintaining your cellular health.

Lifeist is committed to bringing natural products backed by real science to market and looks forward to reaching many more customers in 2024.

About Lifeist Wellness Inc.

Sitting at the forefront of the post-pandemic wellness revolution, Lifeist leverages advancements in science and technology to build breakthrough companies that transform human wellness. Portfolio business units include: Mikra, a biosciences and consumer wellness company developing and selling innovative products for cellular health; CannMart, which operates a B2B wholesale distribution business facilitating recreational cannabis sales to Canadian provincial government control boards including for CannMart Labs, a BHO extraction facility producing high margin cannabis 2.0 products; and Australian Vapes, one of Australia's largest online retailers of vaporizers and accessories.

Information on Lifeist and its businesses can be accessed through the links below:

www.lifeist.com
https://wearemikra.com/
https://cannmart.com
www.australianvaporizers.com.au

Contact:
Meni Morim
CEO
Lifeist Wellness Inc.
Ph: 647-362-0390
Email: [email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.

Forward Looking Information

This news release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as "may", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen.

The forward-looking information contained herein are made as of the date of this news release and are based on assumptions management believed to be reasonable at the time such statements were made, including without limitation, its expectation that the nutraceutical market will develop as currently anticipated, the nutraceutical market will continue to be a multi-billion dollar high-margin market, the introduction of new products and brands will generate additional revenue, expectations that CELLF, RESCUE, SERENITY, PROTECT and other new nutraceutical products to be developed by Mikra will gain market acceptance along with the expansion of the market for nutraceutical products, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this news release. Such factors include, without limitation: the inability of the Company to develop Mikra's business as anticipated, unanticipated changes to current regulations that would adversely impact Mikra's business, unforeseen developments that would delay Mikra's ability to sell newly developed nutraceutical products, the risk that the expected demand for nutraceutical products in general and those of Mikra in particular does not develop as anticipated and risks relating to the Company's ability to execute its business strategy and the benefits realizable therefrom. Additional risk factors can also be found in the Company's current MD&A filed under the Company's SEDAR profile at www.sedar.com. Readers are cautioned not to put undue reliance on forward-looking information. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Source: Lifeist Wellness Inc.


1 Potential Benefits of Aronia Melanocarpa Fruits and Their Constituents in Improving Human Health - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696386/

2 Immune-enhancing role of vitamin C and zinc and effect on clinical conditions - https://pubmed.ncbi.nlm.nih.gov/16373990/



These press releases may also interest you

at 00:45
4P-Pharma, a Lille-based clinical-stage startup studio focused on developing curative therapies for untreated serious diseases, announces that it has successfully secured a total capital of ?15 million in its second closing with participation from...

at 00:20
PROTEINA announced today that it has held a kickoff meeting with Professor Janghee Woo and his research team at Emory University School of Medicine in Atlanta, to begin global clinical validation of its flagship product, PPI PathFinder BCL2 Dx. PPI...

at 00:00
Building on its commitment to identify strengths and gaps in the R&D pipeline for antivirals, the INTREPID Alliance, a consortium of innovative biopharmaceutical companies dedicated to accelerating antiviral treatments to help protect the world ahead...

at 00:00
Spectrum Dynamic's customers will...

28 avr 2024
AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early Alzheimer's disease clinical trial. EMA now aligns with the U.S. Food and Drug Administration (FDA)...

28 avr 2024
Celltrion USA announced today that it has signed an agreement with Express Scripts, one of the nation's leading pharmacy benefit managers (PBMs) negotiating on behalf of health plans covering more than 100 million people. The agreement, effective...



News published on and distributed by: